CORTEX PHARMACEUTICALS INC/DE/
Net SellingCOR·US·🇺🇸 US
9%buys·91%sales
1,978 transactions$3.0MTotal buys·62 buys
$38.3BTotal sells·620 sells
8888 insiders
Last: Apr 1, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 1, 26 | Krikorian Lazarus | Grant | - | |
| Dec 28, 21 | BUA JEAN A | Disposition | - | |
| Dec 28, 21 | Chambliss Kelly C | Disposition | - | |
| Dec 28, 21 | HIGGINS PATRICIA | Disposition | - | |
| Dec 28, 21 | Koehler Michael R | Disposition | - | |
| Dec 28, 21 | Millegan Michael | Disposition | - | |
| Dec 28, 21 | WILSON DAVID A | Disposition | - | |
| Dec 28, 21 | Szurek Paul E. | Disposition | - | |
| Dec 28, 21 | BUA JEAN A | Disposition | - | |
| Dec 28, 21 | HIGGINS PATRICIA | Disposition | - |
CORTEX PHARMACEUTICALS INC/DE/ (COR) has recorded 1 978 insider transactions from 88 insiders. Total insider buying volume stands at $3.0M, while total selling volume is $38.3B. Overall insider sentiment is bearish (91% sales).
CORTEX PHARMACEUTICALS INC/DE/ (COR) has recorded 1 978 insider operations, including 62 open-market purchases ($3.0M), 620 sales ($38.3B) and 1 296 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (91% sales).
Recent activity is concentrated over 1 months in the last year.
Among the most active insiders are Szurek Paul E. (CEO), STAPLE PETER D (CEO) & MANUSO JAMES S J (CEO), with respectively 117, 112, 86 transactions.
Across all 1 978 recorded transactions, the breakdown by type is: sales (620, 31%), grant (604, 31%), exercise (526, 27%), gift (77, 4%), buys (62, 3%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
CORTEX PHARMACEUTICALS INC/DE/ has recorded 1 978 insider operations in total, including 62 open-market purchases ($3.0M), 620 sales ($38.3B) and 1 296 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on April 1, 2026.
Insiders at CORTEX PHARMACEUTICALS INC/DE/ are currently net sellers, with 9% purchases and 91% sales across all reported transactions. Total buy volume is $3.0M versus $38.3B in sales, indicating a bearish insider sentiment.
InsiderLens tracks 88 insiders at CORTEX PHARMACEUTICALS INC/DE/ (COR). Szurek Paul E. (CEO, 117 tx), STAPLE PETER D (CEO, 112 tx), MANUSO JAMES S J (CEO, 86 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for COR is bearish, based on a 9% buy ratio across 682 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for CORTEX PHARMACEUTICALS INC/DE/ comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.